Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $113.49 billion. The enterprise value is $134.14 billion.
| Market Cap | 113.49B |
| Enterprise Value | 134.14B |
Important Dates
The next estimated earnings date is Tuesday, August 19, 2025, before market open.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | Jun 27, 2025 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -3.03% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -3.03% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 86.81% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 24.54 and the forward PE ratio is 15.96. Medtronic's PEG ratio is 2.99.
| PE Ratio | 24.54 |
| Forward PE | 15.96 |
| PS Ratio | 3.40 |
| Forward PS | 3.18 |
| PB Ratio | 2.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 21.89 |
| P/OCF Ratio | 16.11 |
| PEG Ratio | 2.99 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.72, with an EV/FCF ratio of 25.87.
| EV / Earnings | 28.77 |
| EV / Sales | 4.00 |
| EV / EBITDA | 14.72 |
| EV / EBIT | 20.95 |
| EV / FCF | 25.87 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.61.
| Current Ratio | 1.85 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.61 |
| Debt / EBITDA | 3.15 |
| Debt / FCF | 5.71 |
| Interest Coverage | 8.78 |
Financial Efficiency
Return on equity (ROE) is 9.51% and return on invested capital (ROIC) is 5.19%.
| Return on Equity (ROE) | 9.51% |
| Return on Assets (ROA) | 4.41% |
| Return on Invested Capital (ROIC) | 5.19% |
| Return on Capital Employed (ROCE) | 8.13% |
| Revenue Per Employee | $353,021 |
| Profits Per Employee | $49,074 |
| Employee Count | 95,000 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.17 |
Taxes
In the past 12 months, Medtronic has paid $936.00 million in taxes.
| Income Tax | 936.00M |
| Effective Tax Rate | 16.63% |
Stock Price Statistics
The stock price has increased by +14.14% in the last 52 weeks. The beta is 0.82, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +14.14% |
| 50-Day Moving Average | 85.41 |
| 200-Day Moving Average | 87.07 |
| Relative Strength Index (RSI) | 60.59 |
| Average Volume (20 Days) | 7,944,761 |
Short Selling Information
The latest short interest is 8.47 million, so 0.66% of the outstanding shares have been sold short.
| Short Interest | 8.47M |
| Short Previous Month | 13.63M |
| Short % of Shares Out | 0.66% |
| Short % of Float | 0.66% |
| Short Ratio (days to cover) | 1.01 |
Income Statement
In the last 12 months, Medtronic had revenue of $33.54 billion and earned $4.66 billion in profits. Earnings per share was $3.61.
| Revenue | 33.54B |
| Gross Profit | 21.93B |
| Operating Income | 6.40B |
| Pretax Income | 4.81B |
| Net Income | 4.66B |
| EBITDA | 9.11B |
| EBIT | 6.40B |
| Earnings Per Share (EPS) | $3.61 |
Balance Sheet
The company has $8.97 billion in cash and $29.63 billion in debt, giving a net cash position of -$20.64 billion or -$16.11 per share.
| Cash & Cash Equivalents | 8.97B |
| Total Debt | 29.63B |
| Net Cash | -20.64B |
| Net Cash Per Share | -$16.11 |
| Equity (Book Value) | 48.26B |
| Book Value Per Share | 37.46 |
| Working Capital | 10.94B |
Cash Flow
In the last 12 months, operating cash flow was $7.04 billion and capital expenditures -$1.86 billion, giving a free cash flow of $5.19 billion.
| Operating Cash Flow | 7.04B |
| Capital Expenditures | -1.86B |
| Free Cash Flow | 5.19B |
| FCF Per Share | $4.05 |
Margins
Gross margin is 65.39%, with operating and profit margins of 19.09% and 13.90%.
| Gross Margin | 65.39% |
| Operating Margin | 19.09% |
| Pretax Margin | 16.78% |
| Profit Margin | 13.90% |
| EBITDA Margin | 27.17% |
| EBIT Margin | 19.09% |
| FCF Margin | 15.46% |
Dividends & Yields
This stock pays an annual dividend of $2.84, which amounts to a dividend yield of 3.24%.
| Dividend Per Share | $2.84 |
| Dividend Yield | 3.24% |
| Dividend Growth (YoY) | 1.44% |
| Years of Dividend Growth | 49 |
| Payout Ratio | 77.84% |
| Buyback Yield | 3.03% |
| Shareholder Yield | 6.24% |
| Earnings Yield | 4.11% |
| FCF Yield | 4.57% |
Analyst Forecast
The average price target for Medtronic is $98.14, which is 10.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $98.14 |
| Price Target Difference | 10.79% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 5.32% |
| EPS Growth Forecast (5Y) | 15.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.74 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.74 |
| Piotroski F-Score | 5 |